Company Filing History:
Years Active: 2014
Title: Ivan Cornella Taracido: Innovator in Vps34 Inhibition
Introduction
Ivan Cornella Taracido is a notable inventor based in Somerville, MA (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that inhibit Vps34, a protein associated with various diseases.
Latest Patents
Ivan holds 2 patents related to bi-heteroaryl compounds as Vps34 inhibitors. His inventions include novel methods for treating diseases characterized by hyperactivity of Vps34. These patents detail compounds of Formula I and their pharmaceutically acceptable salts, as well as methods for treating hyperproliferative diseases associated with Vps34 inhibition. The pharmaceutical compositions he developed include these innovative compounds, showcasing his commitment to advancing medical treatments.
Career Highlights
Ivan is currently employed at Novartis AG, a leading global healthcare company. His work focuses on the intersection of chemistry and medicine, where he applies his expertise to develop new therapeutic strategies.
Collaborations
Ivan collaborates with esteemed colleagues such as Edmund M Harrington and Ayako Honda. Their combined efforts contribute to the innovative research and development at Novartis AG.
Conclusion
Ivan Cornella Taracido is a prominent figure in the field of pharmaceutical innovation, with a focus on Vps34 inhibitors. His patents and collaborations reflect his dedication to improving healthcare through scientific advancements.